Jiangsu Nhwa Pharmaceutical (002262) Stock Overview

Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company's products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies. The company was founded in 1978 and is headquartered in Xuzhou, China.